Found: 4
Select item for more details and to access through your institution.
In vitro dose comparison of Respimat® inhaler with dry powder inhalers for COPD maintenance therapy.
- Published in:
- International Journal of COPD, 2017, v. 12, p. 1565, doi. 10.2147/COPD.S115886
- By:
- Publication type:
- Article
Complaint management of a quality defect in a nanoparticulate Imiquimod formulation in an investigator initiated academic phase I/II clinical trial Part 2.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2023, v. 85, n. 3, p. 294
- By:
- Publication type:
- Article
Complaint management of a quality defect in a nanoparticulate Imiquimod formulation in an investigator initiated academic phase I/II clinical trial.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2023, v. 85, n. 2, p. 182
- By:
- Publication type:
- Article
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 514, doi. 10.3390/pharmaceutics15020514
- By:
- Publication type:
- Article